WelChol® With Metformin in Treating Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions
Type 2 Diabetes
Interventions
DRUG

Colesevelam hydrochloride

Trial Locations (48)

Unknown

CRO, Jonesboro

Beverly Hills

Carmichael

Fresno

Irvine

La Jolla

Los Gatos

San Diego

Spring Valley

West Hills

Washington D.C.

Coco Beach

Largo

Miami

Pembroke Pines

West Palm Beach

Atlanta

Evansville

Louisville

Detroit

Troy

Edina

Chesterfield

Bozeman

Butte

Las Vegas

Rochester

Charlotte

Winston-Salem

Cincinnati

Cleveland

Lyndhurst

Marion

Oklahoma City

Tulsa

Portland

Beaver

Charleston

Columbia

Morristown

Corpus Christi

Dallas

Pharr

San Antonio

Arlington

Richmond

Mexico City

Lima

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Daiichi Sankyo

INDUSTRY

NCT00147719 - WelChol® With Metformin in Treating Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter